This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
Ezrin (Thr567)/Radixin (Thr564)/Moesin (Thr558) Antibody, phospho-specific
catalog :
AB3832
quantity :
100 μL
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
citations: 1
product information
Catalog Number :
AB3832
Subcategory :
Cell Structure
Product Name :
Anti-Ezrin (Thr567)/Radixin (Thr564)/Moesin (Thr558) Antibody, phospho-specific
Product Type :
Antibodies
Clonality :
Polyclonal Antibody
Gene ID :
O14745
Host Name :
Rabbit
Antigen :
Ezrin/Radixin/Moesin
Conjugate :
Affinity Purified
Product Description :
Anti-Ezrin (Thr567)/Radixin (Thr564)/Moesin (Thr558) Antibody, phospho-specific
Cross Reactivity :
Human;Mouse;Monkey;Rat
Immunogen :
KLH-conjugated, synthetic phospho-peptide corresponding to residues surrounding Thr567 of human ezrin
Specificity :
Recognizes Thr567 phosphorylated ezrin, Thr564 phosphorylated radixin, and Thr558 phosphorylated moesin. Antibody does not cross-react with other related phospho proteins such as merlin or band 4.1.
Package Size :
100 μL
Uses :
Immunohistochemistry (Paraffin);Western Blotting
Storage :
Maintain at -20°C for 12 months, do not aliquot.
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments